Company news
Chosa Oncology Ab (NGM:CHOSA) news
Chosa Oncology Ab news releases on 6ix. Latest, Jul 15, 2026: Chosa Oncology : announces the result of exercise of warrants TO2
Press releases & updates
Chosa Oncology : announces the result of exercise of warrants TO2
July 15, 2026
CHOSA: Chosa Oncology announces the result of exercise of warrants TO2
July 15, 2026
Chosa Oncology : Members of executive management participate in the ongoing warrant - exercise ending tomorrow
July 13, 2026
CHOSA: Members of executive management participate in the ongoing warrant - exercise ending tomorrow
July 13, 2026
CHOSA: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP
July 10, 2026
CHOSA Oncology in connection with the TO2 warrant exercise
July 1, 2026
CHOSA Oncology : establishes US presence in Boston to support commercialization of Platin-DRP
June 23, 2026
CHOSA: CHOSA Oncology establishes US presence in Boston to support commercialization of Platin-DRP
June 23, 2026
CHOSA: Strategic progress and positive clinical data drive momentum, supported by strengthened finances
May 27, 2026
Chosa Oncology : Årsredovisning 2025 (in English - unofficial translation) (CHOSA Oncology AR 2025 UK Version)
May 9, 2026
Chosa Oncology : Annual report 2025 (in English - unofficial translation) (CHOSA Oncology AR 2025 UK Version)
May 9, 2026
Chosa Oncology : Proposal for resolution on authorization regarding issues (Proposal for resolution on authorization regarding issues 2026 4gdr)
April 24, 2026
Chosa Oncology : Power of Attorney (Power of Attorney 2026 m52n)
April 24, 2026
Chosa Oncology : Notice of annual general meeting (Notice of annual general meeting 2026 reem)
April 24, 2026
Chosa Oncology : Proposal for resolution on authorization regarding issues (Proposal for resolution on authorization regarding issues 2026)
April 24, 2026
Chosa Oncology : Notice of annual general meeting (Notice of annual general meeting 2026)
April 24, 2026
Chosa Oncology : Power of Attorney (Power of Attorney 2026)
April 24, 2026
Chosa Oncology : to present new Platin-DRP® data at ASCO 2026
April 24, 2026
CHOSA: CHOSA to present new Platin-DRP® data at ASCO 2026
April 24, 2026
CHOSA: High Platin-DRP® scores predict significantly longer survival in advanced NSCLC
March 26, 2026
Chosa Oncology : Årsredovisning 2025 (in English) (CHOSA Oncology 2025 Year End Report UK 899x)
March 23, 2026
Chosa Oncology : Annual report 2025 (CHOSA Oncology 2025 Year End Report UK)
March 23, 2026
Chosa Oncology : to present Platin-DRP data predicting survival benefit from Carboplatin and Cisplatin in patients with advanced NSCLC from a Phase III study at the 2026 European Lung Cancer Congress
March 19, 2026
CHOSA: CHOSA to present Platin-DRP data predicting survival benefit from Carboplatin and Cisplatin in patients with advanced NSCLC from a Phase III study at the 2026 European Lung Cancer Congress
March 19, 2026
CHOSA: Platin-DRP® showed strong clinical progress in 2025, with funding secured into 2027
February 26, 2026
Chosa Oncology : Precision Oncology patent application targeting Platinum Response and Immunotherapy Synergy
January 23, 2026
CHOSA: Precision Oncology patent application targeting Platinum Response and Immunotherapy Synergy
January 23, 2026
CHOSA: Significant clinical progress and strengthened financial position with new capital raised in Q3 2025
November 13, 2025
CHOSA: Strong Q2 results, clinical progress, and capital raises position for key data in Q3 2025
August 28, 2025
CHOSA: Proprietary technology doubles chemo efficacy, with key clinical and partnership milestones ahead
June 17, 2025
CHOSA: DRP® platform expansion and clinical progress drive CHOSA Oncology's Q1 2025 focus
May 30, 2025
CHOSA: Net loss narrows as CHOSA Oncology advances clinical validation but faces funding risks
February 28, 2025
CHOSA: Q3 net loss narrowed, financials strengthened, and board expertise expanded with Prof. Hirsch
November 11, 2024
CHOSA: Q2 loss narrowed and cash reserves grew as CHOSA advanced oncology partnerships and technology
August 30, 2024